These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9331609)

  • 21. Risk factors associated with abscess formation among patient with leg erysipelas (cellulitis) in sub-Saharan Africa: a multicenter study.
    Pitché PV; Saka B; Diatta AB; Faye O; Diané BF; Sangaré A; Niamba P; Mandengue C; Kobengue L; Diop A; Ly F; Dieng MT; Dicko A; Soumah MM; Cissé M; Kourouma SH; Kouassi I; Boukari T; Akakpo S; Landoh DE; Tchangaï-Walla K
    BMC Dermatol; 2015 Dec; 15():18. PubMed ID: 26666633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological data and comorbidities of 428 patients hospitalized with erysipelas.
    Pereira de Godoy JM; Galacini Massari P; Yoshino Rosinha M; Marinelli Brandão R; Foroni Casas AL
    Angiology; 2010 Jul; 61(5):492-4. PubMed ID: 20147345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].
    Crickx B; Chevron F; Sigal-Nahum M; Bilet S; Faucher F; Picard C; Lazareth I; Belaich S
    Ann Dermatol Venereol; 1991; 118(1):11-6. PubMed ID: 2018300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrent erysipelas].
    Konopík J
    Med Klin; 1967 Jul; 62(30):1162-4. PubMed ID: 5594894
    [No Abstract]   [Full Text] [Related]  

  • 25. [Demographic, clinical and laboratory characteristics of erisypelas in the period 2001-2010].
    Vâţă D; Solovăstru LG; Vâţă A; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1042-7. PubMed ID: 22276443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elephantiasis nostras verrucosa secondary to recurrent erysipelas.
    Freitas A; Rodrigues JFM
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28838924
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibiotic use in patients with erysipelas: a retrospective study.
    Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
    Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemorrhagic erysipelas of the lower limbs: 5 cases].
    Legoupil D; Kupfer-Bessaguet I; Le Brun K; Saraux A; Plantin P
    Ann Dermatol Venereol; 2004; 131(8-9):833. PubMed ID: 15505557
    [No Abstract]   [Full Text] [Related]  

  • 29. [Penicillin G and erysipelas--still being used?].
    Graninger W
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):245-6. PubMed ID: 16370471
    [No Abstract]   [Full Text] [Related]  

  • 30. Penicillin as a therapeutic option in the treatment of in-hospital erysipelas.
    Pereira De Godoy JM; Ribeiro A; Cozzetto De Oliveira AL; Batigalia F
    G Ital Dermatol Venereol; 2014 Feb; 149(1):150-1. PubMed ID: 24566577
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intralymphatic antibiotic therapy in erysipelas of the lower limbs].
    Ermolov AS; Cherkasov VL; Udovskiĭ EE; Samotolkin KN; Ryskind RR; Grigorian AR; Mamedov BA
    Sov Med; 1989; (8):95-9. PubMed ID: 2814680
    [No Abstract]   [Full Text] [Related]  

  • 32. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.
    Lazzarini L; Conti E; Tositti G; de Lalla F
    J Infect; 2005 Dec; 51(5):383-9. PubMed ID: 16321649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phlebitis and Candida albicans infection associated with relapsing erysipelas: a case report.
    Schneider I; Husz S; Thury G; Párducz A
    Int J Dermatol; 1974; 13(2):51-5. PubMed ID: 4596284
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of pyrogenal in the combined therapy of erysipelas].
    Zhivitsa LV; Zeĭgermakher GA; Knysh EN; Predeina VA
    Vrach Delo; 1986 Oct; (10):24-6. PubMed ID: 3798883
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems of the epizootiology and treatment of erysipelas in the white amur].
    Iashchuk VD
    Veterinariia; 1968 Dec; 45(12):76-8. PubMed ID: 5754488
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of reduction operation with genital lymphedema on the frequency of erysipelas and the quality of life.
    Zvonik M; Földi E; Felmerer G
    Lymphology; 2011 Sep; 44(3):121-30. PubMed ID: 22165582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complex treatment of erysipelas in a surgical clinic].
    Iusupov IA; Iafarov RM
    Vestn Khir Im I I Grek; 1986 Jun; 136(6):75-8. PubMed ID: 3750718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostaglandins in erysipelas].
    Cherkasov VL; Bol'shakova TD; Meshcheriakova SV; Mikerin SM
    Sov Med; 1986; (8):26-8. PubMed ID: 3465043
    [No Abstract]   [Full Text] [Related]  

  • 39. [Item 87--Mucocutaneous bacterial infections].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A32-9. PubMed ID: 23176858
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficacy of the action of helium-neon laser radiation in treating erysipelas patients].
    Chernaia TT; Zablotskaia SI
    Vrach Delo; 1988 Sep; (9):110-2. PubMed ID: 3212979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.